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One of the features of long surviving, passively enhanced kidney allografts is their 
failure to induce repeated and sustained rejection episodes. Theoretically, this could 
be attributed to the  induction of immunological unresponsiveness in  the recipient, 
and/or to antigenic changes in the kidney graft. There is ample evidence showing 
that the immune response of the long-surviving recipient is specifically suppressed in 
some, but not all, respects (1-4), whereas the graft appears to have a normal and full 
complement of major histocompatibility antigens as measured by antibody absorption 
(5)  or  radioactively labeled  antibody uptake  (6).  However, the  presence of major 
histocompatibility complex (MHC) t  gene products on a  tissue does not  necessarily 
confer alloimmunogenicity. Platelets, erythrocytes, partially purified lymphocyte or 
liver membranes,  and  liposomes bearing  Ag-B  (rat  H-l)  antigens  are  examples of 
natural  or artificial cell membranes  which  fail  to elicit  T-cell dependent,  primary 
alloimmune  responses  despite  injection of one to  three  orders  of magnitude  more 
MHC  specificity than  that  present  on  an  immunogenic  dose  of intact  allogeneic 
lymphocytes  (7,  8,  and  our  unpublished  results).  As  rat  Ia-like  alloantigens  were 
present on both the lymphocyte membranes and liposomes, failure to induce T-cell 
dependent, primary alloimmune responses cannot be attributed to absence of these 
antigens, and it is evident that additional factors are involved. 
It  is  therefore possible that  although  long surviving, passively enhanced  kidneys 
carry  MHC  antigen,  they  may  nonetheless  be  poorly  or  nonimmunogenic.  This 
possibility is supported by two brief previous studies in which the retransplantation 
of immunologically enhanced  kidneys  was  accompanied  by  the  delayed  onset  of 
rejection  (9,  10).  The  experiments  in  this  present  study  were  undertaken  to  test 
directly the  immunogenicity of long surviving,  passively  enhanced  kidneys.  They 
show that  in  the  (AS  ×  AUG)F1  donor to AS  recipient strain  combination,  such 
kidneys when retransplanted into nonimmune secondary AS recipients do not induce 
normal T-cell dependent immune responses; instead the grafts survive for prolonged 
* Supported by grants from the East Grinstead Research Trust, and the Medical Research Council. 
:~ Present address: Department of Immunology, Royal Postgraduate Medical School, Hammersmith 
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1  Abbrevzations  used in this paper: CFT, complement  fixation  test; MHC, major histoeompatibility  complex; 
PBS, phosphate-buffered  saline; 1  °, primary; 2  °, secondary. 
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periods, and induce a  state of nonresponsiveness. If the secondary AS recipients were 
previously sensitized against  AUG tissue,  strong  immune responses occur  and  the 
kidneys are acutely rejected. 
Materials and Methods 
Animals.  We used the following inbred strains, or hybrids derived from them: AS (Ag-B  1 or 
H-le); AUG (Ag-B  5 or H-It); and WF (Ag-B  2 or H-lW). Rats were bred and maintained at this 
laboratory. 
Kidney  Transplants.  These were performed by conventional microsurgical technique with 
end to end anastamoses of the renal vessels, and the ureter. Grafts were transplanted into the 
left orthotopic position; recipients own remaining  right kidneys were removed 7 d later. Animals 
were inspected at 1- to 2-d intervals for survival. Dead animals were autopsied and the kidneys 
were  examined  histologically unless  advanced  postmortem  changes  were  present.  Passive 
enhancement of (AS  ×  AUG)FI, kidneys transplanted into AS  recipients was  induced as 
previously described  (11),  by  injecting 0.5  ml  of AS  anti-AUG strain  antiserum i.v.  into 
transplant recipients at the completion of the vascular anastamoses. Some rats also received an 
additional similar dose of enhancing serum i.p. 24 h later. 
Lymphocytotoxicity Tests.  Cells (10 ~1 of a  2  ×  106/ml peripheral lymphocyte suspension in 
complement fixation test  (CFT) buffer) were added to a  10 btl of antibody dilution in the wells 
of U-form microtiter test plates.  10 #1 of guinea pig or rat complement (see below) was added 
immediately and incubation continued for 60 min at 20°C. After incubation, plates were held 
inverted and excess fluid removed by a short sharp downward motion of the arm. 10 ~1 of a 2% 
trypan blue (in 1.5 strength phosphate-buffered saline [PBS]) was then added to each well and 
4/~1 of each mixture transferred to a well of a Terasaki plate for reading. This method is based 
on the trypan blue test of Gorer and O'Gorman (12). 
The parallel use of the guinea pig and the rat complements allows convenient detection of 
IgM cytotoxins, because guinea pig serum complements both IgG and IgM rat alloantibody, 
whereas rat serum (13) complements rat IgG alloantibody but not IgM. 
Blood Ureas.  The test-combination Boehringer (Boehringer UK Ltd, Lewes, Sussex, United 
Kingdom) urea enzymatic kits were used with 3-/~1 serum samples; other reagent volumes were 
reduced accordingly. 
Cell-mediated Cytotoxicity.  Effector  cells  consisted  of  peritoneal  lymphocytes  from  which 
adherent cells  had been removed by incubation with glass beads. This assay  system was as 
described previously (14). A centrifugation step  (1,000 rpm for  -~ 20 sec) is included at the 
commencement of effector and target cell incubation,  and one-half  of the supernates is removed 
4 h later, without further centrifugation. The percentage of specific ~lCr release was calculated 
by the formula: 
Experimental release  (cpm) -  spontaneous release  (cpm)  ×  100. 
Total radioactivity incorporated in target cells (cpm). 
Results 
Long Surviving, Passively Enhanced Kidney Allografts Fail to Induce Acute Rejection  in Naive 
Secondary Recipients.  Passively enhanced (AS  X  AUG)F1 kidneys which had been in 
residence for 1-3 mo in AS recipients were retransplanted into naive AS rats (Fig.  1). 
The survival times of 10 such naive, secondary AS recipients are shown in Table I; 
prolonged survival of all rats was observed, 4 of the 10 continuing  to survive for >  100 
d.  As controls, seven naive AS rats were transplanted with normal (AS  ×  AUG)F1 
kidneys. Their survival times were 4  ×  10,  2  ×  11,  and  12 d, results similar to our 
previous experience (15).  Histological examination of the control allografts removed 
at  death  showed  the  presence of advanced rejection. The  blood urea levels of the 
controls and the naive, secondary AS recipients are shown in Fig. 2 and conform to 
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TABLE  I 
Survival of Retransplanted (AS ×  AUG)Fa (5 Kidneys in Secondary AS (5 
Recipients 
Days in 1  ° as d  Rat No. 2 ° Re-  Survival  Comments  Recipient  eipient 
d 
62  J.513 (N)  29 
70  J.516 (N)  >100 
70  J.517 (N)  51 
Killed in error 
Histology:no rejection 
Hydronephrosis 
Histology:no rejection 
46  J.518 (N)  >100 
107  J.523 (N)  >100 
37  J.524 (N)  37  Advanced p.m. changes 
34  J.529 (N')  >100 
27  J.531  (N)  70  Advanced p.m. changes 
40  J.553 (N)  >70 
39  J.554 (N)  32  Advanced p.m. changes 
48  J.533 (S)  >100 
31  j.535 (s)  11  Histology:rejection 
60  J.544 (S)  10  Histology:rejection 
30  J.545 (S)  I0  No histo|ogy 
42  J.551  (S)  11  Histology:rejection 
41  J.552 (S)  11  Histology:rejection 
N, naive recipient. 
S, sensitized recipient. 
Long Surviving, Passively Enhanced Kidney Allografls Succumb to Acute Rejection  in Sensitized, 
Secondary Recipients.  A similar experiment was performed in which passively enhanced 
(AS  X  AUG)F1 kidneys were  retransplanted to secondary AS recipients, but in this 
case,  the  recipients  had  been  sensitized  against  AUG  strain  lymphocytes  2½-6  mo 
previously. None of the recipients had detectable lymphocytotoxic antibody at serum 458  RETRANSPLANTATION  OF  RAT  KIDNEY  I 
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dilutions of 1:2  or greater at  the  time of transplantation.  Six rats  received kidney 
allografts, and five died with acutely rejected grafts, confirmed by histology in four 
cases (Table I). Three of the five rats, which rejected their grafts acutely, died before 
blood urea estimations were performed. The blood urea levels of the remaining two 
rats in this group and the single long survivor (J.533)  were all >200 mg/100 ml on 
days 9-11. 
Humoral Antibody  Response to Retransplanted  Kidney Allografts.  As might be expected 
from the markedly different patterns of survival, humoral responses differed greatly 
according  to  whether  the  secondary recipients were  naive or had  previously been 
sensitized against AUG lymphocytes. Naive secondary recipients (Table II) produced 
no or low levels of lymphocytotoxic IgM antibody.  No IgG lymphocytotoxins were 
found in their sera. In keeping with previous experience (14)  the control rats grafted 
with normal (AS  X  Aug)F1 kidneys responded with high titres of lymphocytotoxins 
against AUG targets; six of seven of the controls had IgM titers exceeding 1/64 at  7 
d. At 9-10 d, IgG, as well as IgM, lymphocytotoxins were present in their sera. 
The sensitized secondary recipients all produced high titers of IgG lymphocytotoxins 
against AUG cells within 7 d of being transplanted  (Table II). The single rat in this 
group which survived beyond day  11  initially produced IgG lymphocytotoxins, but 
by 3 wk, only IgM lymphocytotoxins were present in its serum. 
Cellular  Immune  Response to Retransplanted  Kidney  Allografis.  Cytotoxic lymphocytes 
were  harvested  from  the  peritoneal  cavities of naive  and  sensitized  secondary AS 
recipients,  control AS  rats  grafted with  normal  (AS  ×  AUG)F1  kidfieys, and  un- 
transplanted  but  hyperimmune AS  rats  given  a  single  challenge of 30-40  million 
AUG lymphocytes on day 0.  Assays for the activity of effector cells from these rats 
against  AUG targets are shown  in  Fig.  3.  It was  possible to harvest only sufficient 
effector cells to test a single effector: target ratio. Therefore, the single ratio of 100:1 
has  been  used  throughout.  The cellular immune  response of the  naive,  secondary 
recipients remained at a consistently low level slowly rising to its maximum on day 
23.  In  contrast,  control  recipients  and  sensitized  secondary  recipients  developed 
substantial responses within 7-8 d. The subsequent fall in cellular immunity seen in BATCHELOR,  WELSH, MAYNARD, AND BURGOS 
TABLE II 
Lymphocytotoxic Antibody Titers* (vs. A UG Targets) in Naive and Sensitized 
Secondary as Recipients 
459 
Rat No.  7/8 d  I0/11 d  14 d  21 d  28 d 
J.513 (N):~  0  0  0  3 (IgM)  0 
J.516 (N)  0  0  0  3 (IgM)  0 
J.517 (N)  0  0  0  0  0 
J.518 (N)  0  0  0  0  0 
J.523 (N)  0  0  0  4 (IgM)  0 
J.524 (N)  0  0  0  0  5 (IgM) 
J.529 (N)  0  0  0  0  0 
J.531 (N)  0  0  0  0  0 
J.553 (N)  1 (IgM)  1 (IgM)  0  0  0 
J.554 (N)  0  8 (IgM)  0  0  5 (IgM) 
J.533 (s):~  6  6  6  6 (IgM)  5 (IgM) 
J.535 (S)  6  6  --  --  -- 
J.544 (S)  6  .... 
J.545 (S)  6  .... 
j.551  (s)  6  6  --  --  -- 
J.552 (S)  6  .... 
S, Sensitized recipient. 
See Table I for details. 
* Titers, highest dilution expressed as reciprocal of log2; end point, 30% kill  of target 
cells; (indicates that the rat is dead). 
:~ N, naive recipient. 
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FIG.  3.  Comparison of cell-mediated immunity  in primary and secondary AS  recipients (naive 
and  sensitized).  Results  are  the  means  of  the  net  chromium  release  produced  by  peritoneal 
lymphocytes from three to five rats. No SE of the means was >3% 51Cr release. Effector: target cell 
ratio =  ]00:1. Target cells were (AS  X  AUG)FI thymocytes. 
the control group coincided with the development of severe uraemia, and has been 
noted previously. Hyperimmune AS rats  (without kidney allografts)  challenged on 
day 0 also showed strong cellular immunity which waned during the 4th wk. 
Development  of Nonresponsiveness  in the Naive Secondary Recipients.  Approximately 2 mo 460  RETRANSPLANTATION OF RAT KIDNEY  I 
TABLE  III 
Blood Urea Levels in 2 ° Recipients after Challenge with (AUG X  WF)FI 
Cells 
Time after challenge 
Day 0  Day 4  Day 7 
First challenge  70.98 ±  7.80  65.9 ±  8.06  56.13 ±  6.44 
Second challenge  68.65 ±  7.78  71.38 ±  10.24  69.7 ±  9.02 
Results, mean  ±  SE in mg/100 ml. 
TABLE  IV 
Lymphocytotoxin Titer* after Challenge of 2 ° as Recipients with (AUG X 
WF)F1 Lymphocytes 
Titer vs. AUG cells  Titer vs. WF cells 
Day 0  Day 4  Day 7  Day 0  Day 4  Day 7 
J.516  0  0  0  0  4  6 
J.518  0  0  0  0  4  6 
j.523  0  0  2  0  2  5 
j.529  0  0  0  0  0  0 
Control  1:]:  5  4  5  5  5  5 
Control 2  6  6  6  5  6  6 
Control 3  6  6  6  3  6  6 
* Titers expressed as in Table 
with (AUG ×  WF)F~ cells. 
:~ Three age- and sex-matched 
ing inocula. 
III, and refer to results after second challenge 
naive AS rats received aliquots of the challeng- 
after they  had  been  allografted, four of the naive secondary recipients  (J.516,  518, 
523,  and  529)  were  challenged with  30  ×  l0  s  (AUG  ×  WF)F1  lymphocytes.  The 
objective here was to determine whether they had been rendered unresponsive to graft 
antigens. Two challenges were given separated by 6 wk, the first being given at least 
7 wk after the retransplantation. After each challenge blood ureas and lymphocyto- 
toxic antibody titers against both AUG and WF target cells were measured. The rats 
remained clinically well after the antigenic challenges and showed stable blood ureas 
(Table  III). There  was  marked  suppression  of the antibody response  against  AUG 
target cells. The titers after the second challenge are shown in Table IV. 
Three of four rats  produced  good responses  against  Wistar cells  (Table  IV)  but 
insufficient data is available for us to say that the suppression is completely specific 
for AUG antigens. It should be noted that antibody produced after the first challenge 
persisted up to the time of the second challenge in the three control rats. The control 
rats therefore have cytotoxic antibody at day 0  (Table IV). 
Assays for cytotoxicity of peritoneal effector lymphocytes (Table V)  showed  that 
the secondary recipients did develop cellular immunity against AUG targets after the 
first challenge, but the pattern was similar to that of a primary response, i.e., the peak 
response did not exceed 20% lysis and occurred during the 2nd wk. After the second 
challenge, the cellular response against AUG cells was greatly reduced.  In contrast, 
the response against WF targets increased markedly after the second challenge. BATCHELOR,  WELSH,  MAYNARD,  AND  BURGOS  461 
TABLE  V 
Cell-mediated Immunity after Challenge of Secondary as Recipients with (,4 UG ×  WF)  F1 Lymphocytes 
Percentage net ~lCr release vs. AUG targets 
First challenge  Second Challenge 
Days  4-5  7  10-12  14  4-5  7  10-12  14 
Secondary recipients  6.59  14.35  18.99  8.72  8.37  7.77  4.95  4.26 
(2.27)  (2.2l)  (1.55)  (1.56) 
Normal AS  8.67  12.73  14.65  4.84  17.26  9.42  5.61  10.13 
0.90) 
Percentage Net 5aCr release vs. WF targets 
Days  4-5  7  10-12  14  4-5  7  10-12  14 
Secondary recipients  3,67  15,06  4.79  10.22  23.64  26.26  15.73  10.44 
(0.98) 
Normal AS  7.25  8.69  16.23  5.02  20.81  13.09  8.11  12.47 
(2.58)  (2.20)  (2.31) 
Results are means of triplicates. Standard deviations are only shown if they are over 10% of the net release. 
Discussion 
The experiments reported here demonstrate the following. 
(a)  Long-surviving kidney allografts, when retransplanted into naive, second AS 
recipients, induced only a  weak alloimmune response; the grafts showed prolonged 
survival, alloantibody responses were either absent or consisted only of IgM, and there 
was a striking reduction in the generation of cytotoxic T  cells. 
(b)  When these second AS recipients were challenged with immunogenic spleen 
cells  they were  found to  be  hyporesponsive;  graft  rejection  was  not  precipitated, 
alloantibody reactive with graft antigens was not formed, and a weak cytotoxic T-cell 
response was induced, but this decreased after a  further challenge. The hyporespon- 
siveness was at least partially specific. 
(c) Long-surviving kidney allografts when retransplanted into sensitized second AS 
recipients are in most cases rapidly rejected; in all cases, strong IgG alloantibody and 
cytotoxic T-cell responses are induced. 
It is worth emphasizing that in the donor/recipient combination used here, normal 
kidney allografts are rejected within 12 d in both naive and sensitized recipients, and 
that graft rejection is accompanied by considerable IgM, IgG, and cytotoxic T-cell 
generation against the graft (14). 
Klein et al. (16) have concluded from studies on thymectomized mice that the anti 
H-2 IgM response appears to be thymus independent, and the IgG response thymus 
dependent. In the rat, alloantibody responses to Ag-B antigens similarly are markedly 
thymus  dependent  (17).  For  the  generation  of cytotoxic T  lymphocytes, there  is 
evidence that activation of a T-cell subset which recognizes I-region determinants, or 
their homologues, is necessary for optimum responses to be generated in vitro (18, 19). 
Cantor and Boyse (20, 21) have identified the helper cell population which recognizes 
I-region differences as Lyt-1  ÷ and have shown that it amplifies the maturation of Lyt- 462  RETRANSPLANTATION OF RAT KIDNEY I 
2,3  + cytotoxic T  cells.  To this extent, the generation of cytotoxic T  cells can also be 
considered as a helper cell influenced phenomenon. Two points are worth noting: (a) 
it is uncertain whether the helper cell population necessary for the production of IgG 
alloantibody  is  the  same  as  that  which  amplifies  the  maturation  of the  Lyt-2,3  + 
cytotoxic T  cell; and (b) maturation of Lyt-2,3  + cytotoxic T  cell can proceed without 
intervention of the Lyt-1  + subset, but the efficiency is very reduced except at high cell 
concentrations. 
The  most  simple explanation  for our present  experiments is  that  long-surviving 
kidney  allografts  are  unable  to  induce  the  T  dependent  part  of the  alloimmune 
response even though they carry MHC antigens. One consequence of the persistent 
presence  of alloantigen  in  these  circumstances  is  that  nonresponsiveness  readily 
develops  except  in  sensitized  second  recipients.  The  IgM  alloantibody  and  weak 
cytotoxic T-cell activity observed in  the  naive  second  recipients represents  the T- 
independent part of the alloimmune response which in this donor/recipient combi- 
nation  is not  powerful enough to cause rapid  rejection. Probably, different donor/ 
recipient combinations will vary in the strength of T-independant responses and this 
will affect the survival times of retransplanted grafts (9,  10). 
It has already been mentioned that the mere presence of  MHC antigen is insufficient 
to  elicit  a  T-dependant  alloimmune  response.  We  have  shown  that  the  following 
preparations,  although  carrying Ag-B  specificities in  concentrations  equivalent  to 
those  present  on  viable  allografts,  failed  to  induce  primary  humoral  or  cellular 
alloimmune responses; platelets, erythrocytes (7), lymphocyte membranes, liver mem- 
branes,  liposomes  carrying Ag-B  (including  IA  like)  antigens  (8),  and  ultra-violet 
irradiated  lymphocytes (our unpublished  observations).  For platelets,  erythrocytes, 
and liver membranes, failure to act as a primary alloimmunogen could be attributed 
to absence or low levels of I-region determinants. However, lymphocyte membranes 
and liposomes which carry the rat homologue of I-region determinants also failed to 
elicit significant primary responses. Lafferty and Woolnough (22) and ourselves have 
concluded that an additional function or signal by the stimulator cells is involved in 
the generation of optimum primary alloimmune responses. The results of this present 
study show that  long surviving, passively enhanced kidney allografts are unable to 
provide this additional signal. 
Whether  I-region  differences are  essential  if allogeneic  cells  are  to  be  effective, 
primary  (allo-)  immunogens  is  not,  at  present,  clear.  In  any  case,  it  seems  most 
probable that  the long-surviving kidney grafts contain I-region determinants.  They 
have  been  demonstrated  on  normal  rat  kidneys  in  excess  of that  which  can  be 
accounted for by passenger cells (23). Formal proof of their presence on long-surviving 
kidneys has not yet been published, but our initial analyses indicate that they are. 
In  the  naive  second  recipients,  the  absence  of a  normal  T-dependent  response 
results in the persistent presence of graft antigen and the development of nonrespon- 
siveness.  This state  is  identical  to that  which  develops in conventionally, passively 
enhanced rats. It strongly suggests that antigen in nonimmunogenic form causes the 
nonresponsiveness  in  both  experimental  systems.  A  corollary of this  view  is  that 
normal  kidney allografts  suffer acute  rejection because alloantigen  is  presented  in 
association with the stimulus causing helper cell activation. The most likely vehicle of 
this  stimulus  is  the  passenger  leucocyte, which  presumably  is  absent  from  long- 
surviving grafts. Recently, the suggestion has been made that  Langerhans cells may BATCHELOR, WELSH, MAYNARD, AND BURGOS  463 
be a particularly effective sourc~ of immunogenic stimulation, and the possibility has 
to be considered that they are the only subpopulation present in a graft which is able 
to induce primary T-dependent alloimmunity (24, 25). 
The requirements for inducing secondary responses are less demanding than those 
needed for primary responses, either in vitro (26, 27) or in vivo (7, 8). The explanation 
given for this is that helper cell activation is not necessary for secondary responses. In 
keeping with this hypothesis, long-surviving kidney allografts when retransplanted to 
sensitized AS recipients induce strong secondary alloantibody responses and significant 
cellular immunity. 
A  number of important implications follow from these experiments. They include 
the concept that pretreatment of a recipient with MHC antigen need not necessarily 
jeopardize the survival of any subsequently transplanted graft. Sensitization is only a 
risk in the naive recipient if the antigen is presented in a form which causes activation 
of T-helper cells. If presented in a  form which does not activate this population, it 
readily induces hypo or nonresponsiveness. Even when T-independent responses are 
elicited, they decrease rather than increase on further exposure to antigen. Therefore, 
MHC  antigen  in  a  form  which  does  not  activate  T-helper ceils  should  now  be 
considered for clinical use to induce specific nonresponsiveness. 
Summary 
Long survival of (AS X  AUG)F1 rat kidney allografts in AS recipients was induced 
by passive enhancement with AS anti-AUG antiserum at the time of grafting. After 
1-3 mo, the kidney allografts were transferred to second AS recipients, either naive or 
sensitized against AUG tissue. Naive second recipients did not reject the grafts acutely 
and  failed  to  mount  T-dependant  immunity  against  AUG  targets.  When  later 
challenged  with  spleen  cells  carrying  the  AUG  haplotype,  the  naive  second  AS 
recipients again failed to mount T-dependent immunity, and were nonresponsive. 
Sensitized  second  AS  recipients  showed  strong  IgM,  IgG,  and  cytotoxic T-cell 
responses after grafting, and the kidneys were rapidly destroyed by immune rejection 
in all but one rat. 
It is concluded that long-surviving kidney allografts fail to activate helper T  cells 
and induce in naive second recipients the same state of unresponsiveness observed in 
the first recipient. 
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